Home » Helsinn Integrative Care Gains FDA Clearance for Xonrid Gel
Helsinn Integrative Care Gains FDA Clearance for Xonrid Gel
Helsinn Integrative Care has received FDA marketing clearance for Xonrid gel which is used for radiotherapy-induced dermatitis.
It is recognized in the EU as a medical device, so the FDA acknowledges it as a device too.
The product is intended to be used for less than 30 days and not on open wounds. — Cynthia Jessup
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May